16-1221958-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_012467.4(TPSG1):​c.796C>T​(p.Arg266Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000548 in 1,612,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00058 ( 0 hom. )

Consequence

TPSG1
NM_012467.4 missense

Scores

3
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.636
Variant links:
Genes affected
TPSG1 (HGNC:14134): (tryptase gamma 1) Tryptases comprise a family of trypsin-like serine proteases, the peptidase family S1. Tryptases are enzymatically active only as heparin-stabilized tetramers, and they are resistant to all known endogenous proteinase inhibitors. Several tryptase genes are clustered on chromosome 16p13.3. There is uncertainty regarding the number of genes in this cluster. Currently four functional genes - alpha I, beta I, beta II and gamma I - have been identified. And beta I has an allelic variant named alpha II, beta II has an allelic variant beta III, also gamma I has an allelic variant gamma II. Beta tryptases appear to be the main isoenzymes expressed in mast cells; whereas in basophils, alpha-tryptases predominant. This gene differs from other members of the tryptase gene family in that it has C-terminal hydrophobic domain, which may serve as a membrane anchor. Tryptases have been implicated as mediators in the pathogenesis of asthma and other allergic and inflammatory disorders. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.05413571).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TPSG1NM_012467.4 linkuse as main transcriptc.796C>T p.Arg266Cys missense_variant 6/6 ENST00000234798.5 NP_036599.4 Q9NRR2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TPSG1ENST00000234798.5 linkuse as main transcriptc.796C>T p.Arg266Cys missense_variant 6/61 NM_012467.4 ENSP00000234798.4 Q9NRR2

Frequencies

GnomAD3 genomes
AF:
0.000263
AC:
40
AN:
152174
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000323
AC:
80
AN:
247544
Hom.:
0
AF XY:
0.000334
AC XY:
45
AN XY:
134624
show subpopulations
Gnomad AFR exome
AF:
0.000128
Gnomad AMR exome
AF:
0.000668
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.000196
Gnomad FIN exome
AF:
0.0000932
Gnomad NFE exome
AF:
0.000405
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000578
AC:
844
AN:
1459814
Hom.:
0
Cov.:
77
AF XY:
0.000541
AC XY:
393
AN XY:
726060
show subpopulations
Gnomad4 AFR exome
AF:
0.0000598
Gnomad4 AMR exome
AF:
0.000671
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000116
Gnomad4 FIN exome
AF:
0.0000768
Gnomad4 NFE exome
AF:
0.000704
Gnomad4 OTH exome
AF:
0.000249
GnomAD4 genome
AF:
0.000263
AC:
40
AN:
152292
Hom.:
0
Cov.:
34
AF XY:
0.000215
AC XY:
16
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.0000962
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000282
Gnomad4 NFE
AF:
0.000426
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000341
Hom.:
0
Bravo
AF:
0.000238
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000248
AC:
30
EpiCase
AF:
0.000545
EpiControl
AF:
0.000415

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 12, 2024The c.796C>T (p.R266C) alteration is located in exon 6 (coding exon 6) of the TPSG1 gene. This alteration results from a C to T substitution at nucleotide position 796, causing the arginine (R) at amino acid position 266 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
16
DANN
Uncertain
0.98
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.025
N
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.054
T
MetaSVM
Uncertain
-0.076
T
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-2.3
N
REVEL
Benign
0.26
Sift
Benign
0.076
T
Sift4G
Uncertain
0.049
D
Vest4
0.28
MVP
0.72
MPC
0.0024
ClinPred
0.027
T
GERP RS
2.1
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs146886017; hg19: chr16-1271958; COSMIC: COSV99326205; COSMIC: COSV99326205; API